Steel Grove Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Steel Grove Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,413	Closed	-$233K	–	181
2018 Q4	$233K	Hold	2,413	–	–	0.03%	281
2018 Q3	$294K	Buy	2,413 +4	+0.2%	+$471	0.04%	255
2018 Q2	$265K	Hold	2,409	–	–	0.04%	263
2018 Q1	$257K	Hold	2,409	–	–	0.04%	264
2017 Q4	$257K	Buy	2,409 +3	+0.1%	+$321	0.04%	255
2017 Q3	$268K	Buy	2,406 +3	+0.1%	+$321	0.05%	239
2017 Q2	$249K	Hold	2,403	–	–	0.04%	242
2017 Q1	$235K	Hold	2,403	–	–	0.04%	245
2016 Q4	$212K	Buy	2,403 +3	+0.1%	+$273	0.04%	234
2016 Q3	$232K	Hold	2,400	–	–	0.05%	172
2016 Q2	$206K	Hold	2,400	–	–	0.05%	168
2016 Q1	$209K	Sell	2,400 -42	-2%	-$3.76K	0.05%	166
2015 Q4	$275K	Buy	2,442 +42	+2%	+$4.56K	0.07%	157
2015 Q3	$243K	Hold	2,400	–	–	0.06%	158
2015 Q2	$295K	Buy	+2,400	New	+$287K	0.07%	135

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Steel Grove Capital Advisors's IBB Position: Q1 2019 in Review

Steel Grove Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 2,413 shares — an estimated $233K sold.

Steel Grove Capital Advisors first reported a position in IBB in Q2 2015 and held it in 15 quarters. The position peaked at $295K in Q2 2015. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

Steel Grove Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
Steel Grove Capital Advisors sold 2,413 iShares Biotechnology ETF shares in Q1 2019, an estimated $233K.
Steel Grove Capital Advisors first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 15 quarters.
Steel Grove Capital Advisors's iShares Biotechnology ETF position peaked at $295K in Q2 2015.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Steel Grove Capital Advisors's 13F filing for Q1 2019, filed 14 May 2019.